As COVID demand surges, BD blueprints $1.2B expansion to jack up prefilled syringe output...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 3, 2020 at 11:02 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via Becton Dickinson masterminded the pre-fillable syringe, and decades later, it's a technology key to the global COVID-19 vaccine rollout. And with pandemic demand surging, BD is planning to shell out $1.2 billion to expand that very business.

    article source